Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2011 Sep;18(9):1457-69.
doi: 10.1038/cdd.2011.75. Epub 2011 Jun 3.

Peculiarities of cell death mechanisms in neutrophils

Affiliations
Review

Peculiarities of cell death mechanisms in neutrophils

B Geering et al. Cell Death Differ. 2011 Sep.

Abstract

Analyses of neutrophil death mechanisms have revealed many similarities with other cell types; however, a few important molecular features make these cells unique executors of cell death mechanisms. For instance, in order to fight invading pathogens, neutrophils possess a potent machinery to produce reactive oxygen species (ROS), the phagocyte nicotinamide adenine dinucleotide phosphate (NADPH) oxidase. Evidence is emerging that these ROS are crucial in the execution of most neutrophil cell death mechanisms. Likewise, neutrophils exhibit many diverse granules that are packed with cytotoxic mediators. Of those, cathepsins were recently shown to activate pro-apoptotic B-cell lymphoma-2 (Bcl-2) family members and caspases, thus acting on apoptosis regulators. Moreover, neutrophils have few mitochondria, which hardly participate in ATP synthesis, as neutrophils gain energy from glycolysis. In spite of relatively low levels of cytochrome c in these cells, the mitochondrial death pathway is functional. In addition to these pecularities defining neutrophil death pathways, neutrophils are terminally differentiated cells, hence they do not divide but undergo apoptosis shortly after maturation. The initial trigger of this spontaneous apoptosis remains to be determined, but may result from low transcription and translation activities in mature neutrophils. Due to the unique biological characteristics of neutrophils, pharmacological intervention of inflammation has revealed unexpected and sometimes disappointing results when neutrophils were among the prime target cells during therapy. In this study, we review the current and emerging models of neutrophil cell death mechanisms with a focus on neutrophil peculiarities.

PubMed Disclaimer

Figures

Figure 1
Figure 1
ROS-mediated neutrophil cell death. Upon exposure of neutrophils to various stimuli (e.g. bacteria, TNF-α or GM-CSF + fMLF), the NADPH oxidase is assembled at cellular and granular membranes and becomes activated. This activation results in extracellular and intracellular ROS generation. Depending on the level and – likely also – localization of ROS produced by the NADPH oxidase, neutrophils may die by apoptosis or necrosis, but may also show increased survival
Figure 2
Figure 2
Molecular mechanisms of neutrophil apoptosis. Neutrophils use different molecular pathways for the execution of apoptosis. Although spontaneous and FAS-induced apoptosis are heavily dependent on the mitochondrial death pathway, TNF-α- and endocytosis-induced apoptosis were shown to be mediated by ROS generation
Figure 3
Figure 3
Potential drug strategies to induce neutrophil apoptosis. Various points of attack can be envisioned to pharmacologically induce neutrophil apoptosis. Although some of the strategies would interfere with molecular pathways in many different cell types, others may target specifically neutrophils. It should be noted that under conditions of neutropenia, increased neutrophil survival might be the therapeutic goal (not shown)

Similar articles

Cited by

References

    1. Athens JW, Haab OP, Raab SO, Mauer AM, Ashenbrucker H, Cartwright GE, et al. Leukokinetic studies. IV. The total blood, circulating and marginal granulocyte pools and the granulocyte turnover rate in normal subjects. J Clin Invest. 1961;40:989–995. - PMC - PubMed
    1. Cartwright GE, Athens JW, Wintrobe MM. The kinetics of granulopoiesis in normal man. Blood. 1964;24:780–803. - PubMed
    1. Simon HU. Neutrophil apoptosis pathways and their modifications in inflammation. Immunol Rev. 2003;193:101–110. - PubMed
    1. Pillay J, den Braber I, Vrisekoop N, Kwast LM, de Boer RJ, Borghans JA, et al. In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5.4 days. Blood. 2010;116:625–627. - PubMed
    1. Furze RC, Rankin SM. The role of the bone marrow in neutrophil clearance under homeostatic conditions in the mouse. Faseb J. 2008;22:3111–3119. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources